Get email alerts when DYN insiders make a move — free, no credit card

DYN Insider Trading & Form 4 Activity

Dyne Therapeutics, Inc.
Last filing: Oct 22, 2026·1 day ago
NEUTRAL · LAST 90 DAYS
100%
buyers
$40K
1 buy
$0
0 sells
$40K
net buying
1
insider
Tracking DYN insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Rhodes Jason P
Director
—
$65.2M
-$65.2M
Kersten Dirk
Director
—
$6.7M
-$6.7M
Cox John
CEO & President
—
$238K
-$238K
Kerr Douglas
Head of R&D and CMO
—
$156K
-$156K
Lucera Erick
Chief Financial Officer
—
$47K
-$47K
Posner Brian S
Director
$40K
—
$40K
Friedl-Naderer Johanna
Chief Commercial Officer
—
$31K
-$31K

Recent transactions

Every Form 4 transaction for DYN, newest first.

AWARD
Kerr Douglas · Head of R&D and CMO
Tx Oct 20·Filed Oct 22·EDGAR ↗
8,000 sh
—
BUY
Posner Brian S · Director
Tx Oct 2·Filed Oct 6·EDGAR ↗
2,500 sh @ $16.00
$40K
SELL10b5-1
Kerr Douglas · Chief Medical Officer
Tx Sep 8·Filed Sep 8·EDGAR ↗
1,290 sh @ $18.88
$24K
SELL10b5-1
Cox John · CEO & President
Tx Sep 8·Filed Sep 8·EDGAR ↗
5,658 sh @ $18.88
$107K
SELL10b5-1
Friedl-Naderer Johanna · Chief Commercial Officer
Tx Sep 8·Filed Sep 8·EDGAR ↗
185 sh @ $18.88
$3K
SELL10b5-1
Friedl-Naderer Johanna · Chief Commercial Officer
Tx Sep 4·Filed Sep 8·EDGAR ↗
900 sh @ $24.35
$22K
SELL10b5-1
Kerr Douglas · Chief Medical Officer
Tx Sep 4·Filed Sep 8·EDGAR ↗
3,745 sh @ $24.35
$91K
SELL10b5-1
Rhodes Jason P · Director
Tx Aug 14·Filed Aug 17·EDGAR ↗
478,377 sh @ $25.00
$12.0M
SELL10b5-1
Rhodes Jason P · Director
Tx Aug 14·Filed Aug 17·EDGAR ↗
322,465 sh @ $25.00
$8.1M
SELL10b5-1
Rhodes Jason P · Director
Tx Aug 14·Filed Aug 17·EDGAR ↗
1,359,674 sh @ $25.00
$34.0M
SELL10b5-1
Friedl-Naderer Johanna · Chief Commercial Officer
Tx Aug 13·Filed Aug 17·EDGAR ↗
226 sh @ $26.28
$6K
SELL10b5-1
Rhodes Jason P · Director
Tx Aug 13·Filed Aug 17·EDGAR ↗
63,643 sh @ $26.20
$1.7M
SELL10b5-1
Rhodes Jason P · Director
Tx Aug 13·Filed Aug 17·EDGAR ↗
94,415 sh @ $26.20
$2.5M
SELL10b5-1
Rhodes Jason P · Director
Tx Aug 13·Filed Aug 17·EDGAR ↗
268,354 sh @ $26.20
$7.0M
SELL10b5-1
Cox John · CEO & President
Tx Aug 13·Filed Aug 17·EDGAR ↗
4,986 sh @ $26.28
$131K
SELL10b5-1
Lucera Erick · Chief Financial Officer
Tx Aug 13·Filed Aug 17·EDGAR ↗
1,797 sh @ $26.28
$47K
SELL10b5-1
Kerr Douglas · Chief Medical Officer
Tx Aug 13·Filed Aug 17·EDGAR ↗
1,556 sh @ $26.28
$41K
SELL10b5-1
Kersten Dirk · Director
Tx Jul 27·Filed Jul 29·EDGAR ↗
5,388 sh @ $26.04
$140K
SELL10b5-1
Kersten Dirk · Director
Tx Jul 27·Filed Jul 29·EDGAR ↗
256,072 sh @ $25.50
$6.5M
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
124,379 sh @ $23.17
$2.9M
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
29,587 sh @ $23.62
$699K
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
62,543 sh @ $23.17
$1.4M
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
14,844 sh @ $23.62
$351K
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
49,193 sh @ $23.17
$1.1M
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
11,665 sh @ $23.62
$276K
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 7·Filed Jul 8·EDGAR ↗
5,000 sh @ $23.61
$118K
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 6·Filed Jul 8·EDGAR ↗
127,182 sh @ $22.79
$2.9M
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 6·Filed Jul 8·EDGAR ↗
253,039 sh @ $22.79
$5.8M
SELL10b5-1
Rhodes Jason P · Director
Tx Jul 6·Filed Jul 8·EDGAR ↗
100,019 sh @ $22.79
$2.3M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 29·Filed Jun 30·EDGAR ↗
51,756 sh @ $21.14
$1.1M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 29·Filed Jun 30·EDGAR ↗
40,702 sh @ $21.14
$860K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 29·Filed Jun 30·EDGAR ↗
102,969 sh @ $21.14
$2.2M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 26·Filed Jun 30·EDGAR ↗
81,903 sh @ $21.28
$1.7M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 26·Filed Jun 30·EDGAR ↗
162,954 sh @ $21.28
$3.5M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 26·Filed Jun 30·EDGAR ↗
64,411 sh @ $21.28
$1.4M
SELL
Lucera Erick · Chief Financial Officer
Tx Jun 25·Filed Jun 26·EDGAR ↗
2,362 sh @ $20.37
$48K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 25·Filed Jun 26·EDGAR ↗
12,699 sh @ $21.10
$268K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 25·Filed Jun 26·EDGAR ↗
6,382 sh @ $21.10
$135K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 25·Filed Jun 26·EDGAR ↗
5,019 sh @ $21.10
$106K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 24·Filed Jun 26·EDGAR ↗
19,973 sh @ $21.02
$420K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 24·Filed Jun 26·EDGAR ↗
25,397 sh @ $21.02
$534K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 24·Filed Jun 26·EDGAR ↗
50,530 sh @ $21.02
$1.1M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 23·Filed Jun 26·EDGAR ↗
77,855 sh @ $21.13
$1.6M
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 23·Filed Jun 26·EDGAR ↗
30,774 sh @ $21.13
$650K
SELL10b5-1
Rhodes Jason P · Director
Tx Jun 23·Filed Jun 26·EDGAR ↗
39,131 sh @ $21.13
$827K
SELL10b5-1
Kersten Dirk · Director
Tx Jun 23·Filed Jun 24·EDGAR ↗
71,629 sh @ $21.04
$1.5M
SELL10b5-1
Kersten Dirk · Director
Tx Jun 23·Filed Jun 24·EDGAR ↗
1,657 sh @ $21.47
$36K
SELL10b5-1
Kersten Dirk · Director
Tx Jun 22·Filed Jun 24·EDGAR ↗
190,676 sh @ $20.57
$3.9M
SELL10b5-1
Kersten Dirk · Director
Tx Jun 18·Filed Jun 22·EDGAR ↗
46,901 sh @ $20.07
$941K
SELL10b5-1
Kersten Dirk · Director
Tx Jun 17·Filed Jun 22·EDGAR ↗
37,454 sh @ $20.14
$754K

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About DYN insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for DYN from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying DYN always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Dyne Therapeutics, Inc. (DYN) when they form.

Where does DYN insider trading data come from?

Every Form 4 filing for DYN is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai